Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Russia authorizes Pfizer to conduct clinical trials for its experimental COVID-19 drug named Paxlovid, which will continue until March 2023

Russia authorizes Pfizer to conduct clinical trials for its experimental COVID-19 drug named Paxlovid, which will continue until March 2023.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthRussia authorizes Pfizer to conduct clinical trials for its experimental COVID-19 drug named Paxlovid, which will continue until March 2023

Russia authorizes Pfizer to conduct clinical trials for its experimental COVID-19 drug named Paxlovid, which will continue until March 2023.

View Premium plansBrowse free archive reports